Insulin Glargine
Insulin Glargine

68.44
A generic medicine indicated for diabetes. Replicates naturally occurring insulin to lower blood glucose concentrations.


Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Insulin glargine
Reference Brand
Lantus
Product Origin
Generic Product
Product Form
Injectable Solution
Regulatory Classification
Prescription Only Medicine
Primary Category
Antidiabetics
Product Category
Long-Acting Insulin Analog
Pharmacological Class
Insulin
Clinical Indications
Manufacturer Description
Designed to support long-term glucose stabilization to manage diabetes mellitus symptoms and alleviate blood sugar spikes.
Mechanism of Action
Binds to cell insulin receptors to stimulate peripheral glucose uptake and block glucose output from hepatic pathways.
Route of Administration
Subcutaneous
Onset Time
1–2 hours
Duration
24 hours
Contraindications
Hypoglycemia, Hypersensitivity to insulin glargine
Severe Adverse Events
Severe anaphylaxis — requires immediate medical attention, Severe hypoglycemia — requires immediate medical attention
Common Side Effects
Injection site redness, Weight gain
Uncommon Side Effects
Hypoglycemia, Lipodystrophy, Mild hypokalemia
Drug Interactions
Beta Blockers, Corticosteroids, Alcohol
Pregnancy Safety Warnings
TGA Category C: Deemed safe and crucial during pregnancy. Breastfeeding: Compatible.
Age Restrictions
Approved for children over two years, adolescents, and adults.
Storage Guidelines
Store between 2°C and 8°C. Do not freeze.
Information related to Insulin Glargine is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
how to buy Menopause Relief - Evista Price